{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:07:44Z","timestamp":1787497664251,"version":"build-2736575974"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"The Danish Kennel Club"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Veterinary Journal"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.tvjl.2015.10.018","type":"journal-article","created":{"date-parts":[[2015,11,27]],"date-time":"2015-11-27T09:00:22Z","timestamp":1448614822000},"page":"44-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["A single-blinded phenobarbital-controlled trial of levetiracetam as mono-therapy in dogs with newly diagnosed epilepsy"],"prefix":"10.1016","volume":"208","author":[{"given":"N.","family":"Freds\u00f8","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sabers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Toft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Berendt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tvjl.2015.10.018_bib0010","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0920-1211(02)00247-4","article-title":"Evidence for sustained efficacy of levetiracetam as add-on epilepsy therapy","volume":"53","author":"Ben-Menachem","year":"2003","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.tvjl.2015.10.018_bib0015","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/j.1939-1676.2007.tb03017.x","article-title":"Premature death, risk factors, and life patterns in dogs with epilepsy","volume":"21","author":"Berendt","year":"2007","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1016\/j.tvjl.2015.10.018_bib0020","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.2460\/javma.240.9.1073","article-title":"Comparison of phenobarbital with bromide as a first-choice antiepileptic drug for treatment of epilepsy in dogs","volume":"240","author":"Boothe","year":"2012","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"10.1016\/j.tvjl.2015.10.018_bib0025","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1212\/01.wnl.0000252941.50833.4a","article-title":"Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy","volume":"68","author":"Brodie","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.tvjl.2015.10.018_bib0030","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1528-1157.1993.tb00433.x","article-title":"Guidelines for epidemiologic studies on epilepsy","volume":"34","author":"Commission on Epidemiology and Prognosis, I.L.A.E.","year":"1993","journal-title":"Epilepsia"},{"key":"10.1016\/j.tvjl.2015.10.018_bib0035","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.eplepsyres.2004.03.006","article-title":"Levetiracetam during 1-year follow-up in children, adolescents, and young adults with refractory epilepsy","volume":"59","author":"Coppola","year":"2004","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.tvjl.2015.10.018_bib0040","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.2460\/javma.1991.199.08.1060","article-title":"Hepatotoxicity of phenobarbital in dogs: 18 cases (1985\u20131989)","volume":"199","author":"Dayrell-Hart","year":"1991","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"10.1016\/j.tvjl.2015.10.018_bib0045","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1476-4431.2008.00294.x","article-title":"Pharmacokinetics of single-dose intravenous levetiracetam administration in normal dogs","volume":"18","author":"Dewey","year":"2008","journal-title":"Journal of Veterinary Emergency and Critical Care"},{"key":"10.1016\/j.tvjl.2015.10.018_bib0050","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1111\/jvim.12443","article-title":"Risk factors for survival in a university hospital population of dogs with epilepsy","volume":"28","author":"Freds\u00f8","year":"2014","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1016\/j.tvjl.2015.10.018_bib0055","first-page":"555","article-title":"Pancreatitis associated with potassium bromide\/phenobarbital combination therapy in epileptic dogs","volume":"41","author":"Gaskill","year":"2000","journal-title":"The Canadian Veterinary Journal"},{"key":"10.1016\/j.tvjl.2015.10.018_bib0060","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1354\/vp.42-2-147","article-title":"Liver histopathology and liver and serum alanine aminotransferase and alkaline phosphatase activities in epileptic dogs receiving phenobarbital","volume":"42","author":"Gaskill","year":"2005","journal-title":"Veterinary Pathology"},{"key":"10.1016\/j.tvjl.2015.10.018_bib0065","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1939-1676.2011.00868.x","article-title":"Double-masked, placebo-controlled study of intravenous levetiracetam for the treatment of status epilepticus and acute repetitive seizures in dogs","volume":"26","author":"Hardy","year":"2012","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1016\/j.tvjl.2015.10.018_bib0070","first-page":"1907","article-title":"Luminal bei epilepsie","volume":"59","author":"Hauptmann","year":"1912","journal-title":"Munchener Medizinische Wochenschrift"},{"key":"10.1016\/j.tvjl.2015.10.018_bib0075","doi-asserted-by":"crossref","first-page":"681","DOI":"10.2460\/javma.1998.212.05.681","article-title":"Neutropenia and thrombocytopenia in three dogs treated with anticonvulsants","volume":"212","author":"Jacobs","year":"1998","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"10.1016\/j.tvjl.2015.10.018_bib0080","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.2165\/00003088-200645110-00002","article-title":"Pharmacokinetic variability of newer antiepileptic drugs: When is monitoring needed?","volume":"45","author":"Johannessen","year":"2006","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1016\/j.tvjl.2015.10.018_bib0085","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2460\/javma.2000.217.200","article-title":"Effect of timing of blood collection on serum phenobarbital concentrations in dogs with epilepsy","volume":"217","author":"Levitski","year":"2000","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"10.1016\/j.tvjl.2015.10.018_bib0090","first-page":"524","article-title":"Discussion on paper by Dr Sieveking: Analysis of fifty-two cases of epilepsy observed by the author","volume":"1","author":"Locock","year":"1857","journal-title":"The Medical Times and Gazette"},{"key":"10.1016\/j.tvjl.2015.10.018_bib0095","first-page":"527","article-title":"Discussion on paper by EH Sieveking: Analysis of fifty-two cases of epilepsy observed by the author","volume":"69","author":"Locock","year":"1857","journal-title":"Lancet"},{"key":"10.1016\/j.tvjl.2015.10.018_bib0100","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1111\/j.1499-1654.2000.001499.x","article-title":"Development of tolerance during chronic treatment of kindled rats with the novel antiepileptic drug levetiracetam","volume":"41","author":"L\u00f6scher","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.tvjl.2015.10.018_bib0105","doi-asserted-by":"crossref","first-page":"9861","DOI":"10.1073\/pnas.0308208101","article-title":"The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam","volume":"101","author":"Lynch","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.tvjl.2015.10.018_bib0110","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1939-1676.2004.tb00137.x","article-title":"Superficial necrolytic dermatitis in 11 dogs with a history of phenobarbital administration (1995\u20132002)","volume":"18","author":"March","year":"2004","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1016\/j.tvjl.2015.10.018_bib0115","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2460\/ajvr.71.3.337","article-title":"Levetiracetam pharmacokinetics in healthy dogs following oral administration of single and multiple doses","volume":"71","author":"Moore","year":"2010","journal-title":"American Journal of Veterinary Research"},{"key":"10.1016\/j.tvjl.2015.10.018_bib0120","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2885.2010.01188.x","article-title":"The pharmacokinetics of levetiracetam in healthy dogs concurrently receiving phenobarbital","volume":"34","author":"Moore","year":"2010","journal-title":"Journal of Veterinary Pharmacology and Therapeutics"},{"key":"10.1016\/j.tvjl.2015.10.018_bib0125","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1939-1676.2011.00866.x","article-title":"Evaluation of levetiracetam as adjunctive treatment for refractory canine epilepsy: A randomized, placebo-controlled, crossover trial","volume":"26","author":"Mu\u00f1ana","year":"2012","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1016\/j.tvjl.2015.10.018_bib0130","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/jvim.12548","article-title":"Effect of chronic administration of phenobarbital, or bromide on pharmacokinetics of levetiracetam in dogs with epilepsy","volume":"29","author":"Mu\u00f1ana","year":"2015","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1016\/j.tvjl.2015.10.018_bib0135","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1939-1676.2000.tb02231.x","article-title":"Effects of long-term phenobarbital treatment on the liver in dogs","volume":"14","author":"M\u00fcller","year":"2000","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1016\/j.tvjl.2015.10.018_bib0140","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S1059131102001723","article-title":"A paradoxical effect of levetiracetam may be seen in both children and adults with refractory epilepsy","volume":"12","author":"Nakken","year":"2003","journal-title":"Seizure: The Journal of the British Epilepsy Association"},{"key":"10.1016\/j.tvjl.2015.10.018_bib0145","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1365-2885.2008.00948.x","article-title":"Intramuscular, intravenous and oral levetiracetam in dogs: Safety and pharmacokinetics","volume":"31","author":"Patterson","year":"2008","journal-title":"Journal of Veterinary Pharmacology and Therapeutics"},{"key":"10.1016\/j.tvjl.2015.10.018_bib0150","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/jvim.12269","article-title":"Levetiracetam rectal administration in healthy dogs","volume":"28","author":"Peters","year":"2014","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1016\/j.tvjl.2015.10.018_bib0155","first-page":"410","article-title":"Levetiracetam therapy for longterm idiopathic epileptic dogs. ACVIM Abstract","volume":"18","author":"Steinberg","year":"2004","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1016\/j.tvjl.2015.10.018_bib0160","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1111\/j.1528-1167.2008.01585.x","article-title":"The risk of paradoxical levetiracetam effect is increased in mentally retarded patients","volume":"49","author":"Szucs","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.tvjl.2015.10.018_bib0165","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/jvp.12151","article-title":"Clinical efficacy and safety of imepitoin in comparison with phenobarbital for the control of idiopathic epilepsy in dogs","volume":"38","author":"Tipold","year":"2015","journal-title":"Journal of Veterinary Pharmacology and Therapeutics"},{"key":"10.1016\/j.tvjl.2015.10.018_bib0175","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.tvjl.2007.03.002","article-title":"The efficacy and tolerability of levetiracetam in pharmacoresistant epileptic dogs","volume":"176","author":"Volk","year":"2008","journal-title":"The Veterinary Journal"}],"container-title":["The Veterinary Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090023315004153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090023315004153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T14:50:24Z","timestamp":1718203824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090023315004153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":33,"alternative-id":["S1090023315004153"],"URL":"https:\/\/doi.org\/10.1016\/j.tvjl.2015.10.018","relation":{},"ISSN":["1090-0233"],"issn-type":[{"value":"1090-0233","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A single-blinded phenobarbital-controlled trial of levetiracetam as mono-therapy in dogs with newly diagnosed epilepsy","name":"articletitle","label":"Article Title"},{"value":"The Veterinary Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tvjl.2015.10.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}